Optimind Pharma Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 0.012863 million compared to USD 0.053972 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% | 0.00% | 0.00% |
26/01 | Optimind Pharma Reaches Agreement On Debenture Conversion | MT |
10/01 | Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 4L | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
+0.96% | 2.23TCr | |
-12.64% | 2.22TCr | |
-4.64% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+7.77% | 1.43TCr | |
+37.41% | 1.25TCr |
- Stock Market
- Equities
- OMND Stock
- News Optimind Pharma Corp.
- Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022